Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.India and Netherlands have signed a memorandum of understanding (MoU) for development of vaccines.
Subscribe to our email newsletter
As part of ‘Make in India’ initiative, Bharat Immunologicals and Biologicals Corporation (BIBCOL) will develop Measles – Rubella vaccine at its plant at Chola, Bulandshahr, Uttar Pradesh, India.
The development of vaccine will receive technical support from Netherlands government-based institute Translational Vaccinology (INTRAVACC).
BIBCOL chairman Dr MK Bhan said that the collaboration will pave the way for manufacture of affordable vaccines starting with Measles and Rubella vaccine, and then lead to the production of other needed vaccines.
Indian Science & Technology and Earth Sciences Minister Dr Harshvardhan said that the vaccine development will help save hundreds of thousands of children from the dreaded disease in the country.
Additionally, development of other vaccines and biologicals with DBT Research Institutes will be explored.
Netherlands’ INTRAVACC is internationally known for vaccine development and technology transfer.